GILEAD SCIENCES BELGIUM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
GILEAD SCIENCES BELGIUM
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€3.2m
2024 · €4.1m-€926,664
Equity
€35.7m
2024 · €32.5m+€3.2m
Cash
€13.0m
2024 · €18.8m-€5.8m
Balance sheet total
€68.7m
2024 · €65.3m+€3.5m
Largest movements
Assets
- Deferred charges and accrued income +€7.9m
up €7.9m (+241%), from €3.3m to €11.1m
- Cash -€5.8m
down €5.8m (-30.8%), from €18.8m to €13.0m
mainly Deferred charges and accrued income (-€7.9m) and Stocks and contracts (-€5.3m)
- Stocks and contracts +€5.3m
up €5.3m (+57.9%), from €9.1m to €14.4m
- Receivables within one year -€3.9m
down €3.9m (-11.6%), from €34.0m to €30.0m
of which Other amounts receivable: -€3.1m
Equity and liabilities
- Profit (loss) carried forward +€3.2m
up €3.2m (+9.9%), from €32.1m to €35.3m
- Trade debts +€1.0m
up €1.0m (+3.7%), from €27.2m to €28.2m
- Tax, wage and social debts -€702,402
down €702,402 (-12.7%), from €5.5m to €4.8m
of which Taxes: -€1.0m
Income statement
- Turnover -€22.9m
down €22.9m (-16.2%), from €141.3m to €118.4m
- Goods and materials -€15.1m
down €15.1m (-14.7%), from €102.5m to €87.4m
of which Purchases: -€12.8m
- Other operating charges -€4.5m
down €4.5m (-30.3%), from €14.8m to €10.3m
- Staff costs -€1.7m
down €1.7m (-13.5%), from €12.3m to €10.6m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€4.1m
Turnover
-€22.9m
Goods and materials
+€15.1m
Services and other goods
+€779,825
Staff costs
+€1.7m
Depreciation
+€9,596
Write-downs
+€13,075
Other operating charges
+€4.5m
Financial income
-€492,685
Financial charges
-€30,544
Taxes
+€393,485
Result 2025
€3.2m
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€5.7m
Investment
-€105,606
Financing
€0
Cash 2024
€18.8m
From operations (derived)
-€5.7m
Net result for the year
+€3.2m
Depreciation
+€32,662
Stocks and contracts
-€5.3m
Receivables within one year
+€3.9m
Deferred charges and accrued income
-€7.9m
Trade debts
+€1.0m
Tax, wage and social debts
-€702,402
Accrued charges and deferred income
-€16,415
Investment (derived)
-€105,606
Investment in fixed assets (net)
-€105,606
Cash 2025
€13.0m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €65,261,093 | €68,736,940 | +€3.5m | +5.3% |
| Fixed assets | 21/28 | €48,249 | €121,192 | +€72,944 | +151% |
| Tangible fixed assets | 22/27 | €42,409 | €115,352 | +€72,944 | +172% |
| Plant, machinery and equipment | 23 | €36,508 | €113,548 | +€77,040 | +211% |
| Furniture and vehicles | 24 | €1,140 | €936 | -€204 | -17.9% |
| Assets under construction and advance payments | 27 | €4,760 | €868 | -€3,892 | -81.8% |
| Financial fixed assets | 28 | €5,840 | €5,840 | = | 0.0% |
| Other financial fixed assets | 284/8 | €5,840 | €5,840 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €5,840 | €5,840 | = | 0.0% |
| Current assets | 29/58 | €65,212,844 | €68,615,747 | +€3.4m | +5.2% |
| Stocks and contracts in progress | 3 | €9,132,894 | €14,416,355 | +€5.3m | +57.9% |
| Stocks | 30/36 | €9,132,894 | €14,416,355 | +€5.3m | +57.9% |
| Goods purchased for resale | 34 | €9,132,894 | €14,416,355 | +€5.3m | +57.9% |
| Amounts receivable within one year | 40/41 | €33,969,106 | €30,023,808 | -€3.9m | -11.6% |
| Trade receivables | 40 | €26,891,614 | €26,072,767 | -€818,847 | -3.0% |
| Other amounts receivable | 41 | €7,077,491 | €3,951,041 | -€3.1m | -44.2% |
| Cash at bank and in hand | 54/58 | €18,838,455 | €13,028,662 | -€5.8m | -30.8% |
| Deferred charges and accrued income | 490/1 | €3,272,390 | €11,146,923 | +€7.9m | +241% |
| Total equity and liabilities | 10/49 | €65,261,093 | €68,736,940 | +€3.5m | +5.3% |
| Equity | 10/15 | €32,507,275 | €35,697,075 | +€3.2m | +9.8% |
| Contributions | 10/11 | €377,905 | €377,905 | = | 0.0% |
| Profit (loss) carried forward | 14 | €32,129,370 | €35,319,170 | +€3.2m | +9.9% |
| Amounts payable | 17/49 | €32,753,818 | €33,039,864 | +€286,046 | +0.9% |
| Amounts payable within one year | 42/48 | €32,729,227 | €33,031,688 | +€302,461 | +0.9% |
| Trade debts | 44 | €27,208,265 | €28,213,128 | +€1.0m | +3.7% |
| Suppliers | 440/4 | €27,208,265 | €28,213,128 | +€1.0m | +3.7% |
| Taxes, remuneration and social security | 45 | €5,520,961 | €4,818,559 | -€702,402 | -12.7% |
| Taxes | 450/3 | €2,074,818 | €1,063,600 | -€1.0m | -48.7% |
| Remuneration and social security | 454/9 | €3,446,143 | €3,754,959 | +€308,816 | +9.0% |
| Accrued charges and deferred income | 492/3 | €24,592 | €8,176 | -€16,415 | -66.8% |
| Operating income | 70/76A | €141,310,654 | €118,449,133 | -€22.9m | -16.2% |
| Turnover | 70 | €141,310,654 | €118,449,133 | -€22.9m | -16.2% |
| Operating charges | 60/66A | €136,354,288 | €114,289,688 | -€22.1m | -16.2% |
| Goods for resale, raw materials and consumables | 60 | €102,494,179 | €87,382,251 | -€15.1m | -14.7% |
| Purchases | 600/8 | €105,457,730 | €92,665,711 | -€12.8m | -12.1% |
| Change in stocks: decrease (increase) | 609 | -€2,963,551 | -€5,283,460 | -€2.3m | -78.3% |
| Services and other goods | 61 | €6,681,581 | €5,901,756 | -€779,825 | -11.7% |
| Remuneration, social security and pensions | 62 | €12,292,479 | €10,635,063 | -€1.7m | -13.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €42,257 | €32,662 | -€9,596 | -22.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €28,987 | €15,911 | -€13,075 | -45.1% |
| Other operating charges | 640/8 | €14,814,804 | €10,322,045 | -€4.5m | -30.3% |
| Operating profit (loss) | 9901 | €4,956,366 | €4,159,446 | -€796,920 | -16.1% |
| Financial income | 75/76B | €984,648 | €491,964 | -€492,685 | -50.0% |
| Recurring financial income | 75 | €984,648 | €491,964 | -€492,685 | -50.0% |
| Income from financial fixed assets | 750 | €959,110 | €491,421 | -€467,689 | -48.8% |
| Other financial income | 752/9 | €25,538 | €543 | -€24,995 | -97.9% |
| Financial charges | 65/66B | €10,556 | €41,100 | +€30,544 | +289% |
| Recurring financial charges | 65 | €10,556 | €41,100 | +€30,544 | +289% |
| Debt charges | 650 | €10,556 | €13,725 | +€3,169 | +30.0% |
| Other financial charges | 652/9 | €0 | €27,375 | +€27,375 | |
| Profit (loss) for the period before taxes | 9903 | €5,930,458 | €4,610,310 | -€1.3m | -22.3% |
| Income taxes | 67/77 | €1,813,994 | €1,420,509 | -€393,485 | -21.7% |
| Taxes | 670/3 | €1,813,994 | €1,420,509 | -€393,485 | -21.7% |
| Profit (loss) for the period | 9904 | €4,116,465 | €3,189,801 | -€926,664 | -22.5% |
| Profit (loss) for the period to be appropriated | 9905 | €4,116,465 | €3,189,801 | -€926,664 | -22.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.